title: [Detection of multiple colon and rectal tumors during diagnostic treatment and follow-up].
abstract: Recognition of the commonly encountered colorectal cancer (CRC) generally begins and takes place because of and based on symptoms and signs, due to the unsettled screening of this type of cancer. Sometimes, because of advanced stage cancer urgent surgical intervention could become necessary and, if this is the case, there is no time and possibility for searching for an eventual second tumor and perhaps the patient's status does not permit performing intraoperative investigations either. The incidence of multiple colon cancer is considered to be between 2.5 and 30% according to the literature. That is why one should exclude them even in the absence of pre- and intraoperative investigations and complaints. On the other hand, colonoscopy and perhaps irrigoscopy of seemingly healthy followed-up patients is mandatory. In the case of the presence of complaints/symptoms denoting impaired intestinal passage seen in a followed-up patient or during the adjuvant setting or metastatic/recurrent disease, treatment and even during hospice care we should evaluate the possibility of a second metachronous tumor. Moreover, if there is no urgency, the multidisciplinary team (oncoteam) should recommend the adequate treatment by balancing gain/utility and risk.
authors: Megyei Onkológiai Központ, Békés Megyei Képviselõtestület Pándy Kálmán Kórháza, Gyula, Hungary. dr.piko.bela@gmail.com
authors: Béla
authors: B
authors: Pikó
authors: Pál
authors: P
authors: Rahóty
authors: Ildikó
authors: I
authors: Krémer
authors: János
authors: J
authors: Zsilák
authors: Enikõ
authors: E
authors: Török
authors: Ali
authors: A
authors: Bassam
authors: Margit
authors: M
authors: Csiffári
authors: Sándor
authors: S
authors: Dimák
authors: Anita
authors: A
authors: Kis
authors: Paul
authors: P
authors: Rus-Gal
authors: Zsolt
authors: Z
authors: Szabó
authors: Blanka
authors: B
authors: Veréb
authors: Klára
authors: K
authors: Puskásné Szatmári
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000097:blood; D001706:Biopsy; D002272:Carcinoembryonic Antigen / Q000097:blood; D003110:Colonic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D003113:Colonoscopy; D003287:Contrast Media; D005500:Follow-Up Studies; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008279:Magnetic Resonance Imaging; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D011159:Population Surveillance / Q000379:methods; D011634:Public Health; D012004:Rectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D012042:Registries; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
chemical_list: D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D003287:Contrast Media